Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Perou, Charles M."'
Autor:
Sun X; Vanderbilt University Medical Center, Nashville, TN, United States., Kennedy LC; Vanderbilt University Medical Center, Nashville, TN, United States., Gonzalez-Ericsson PI; Vanderbilt University Medical Center, Nashville, TN, United States., Sanchez V; Vanderbilt University Medical Center, Nashville, Tennessee, United States., Sanders M; Vanderbilt University Medical Center, Nashville, Tennessee, United States., Perou CM; University of North Carolina School of Medicine, Chapel Hill, NC, United States., Troester MA; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Balko JM; Vanderbilt University, Nashville, TN, United States., Reid SA; Vanderbilt University Medical Center, Nashville, TN, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15. Date of Electronic Publication: 2024 Jul 15.
Autor:
Llombart-Cussac A; Hospital Arnau de Vilanova, Valencia, Spain., Pérez-García J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, NJ, US, Spain., Brasó-Maristany F; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Paré L; Reveal Genomics, Barcelona, Spain., Villacampa G; Institute of Cancer Research, United Kingdom., Gion M; Hospital Universitario Ramon y Cajal, Madrid, Madrid, Spain., Schmid P; Barts Cancer Institute, London, United Kingdom., Colleoni M; European Institute of Oncology, Milan, Italy, Italy., Borrego MR; Complejo Hospitalario Virgen del Rocío, Sevilla, Sevilla, Spain., Galván P; August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain., Parker JS; University of North Carolina School of Medicine, Chapel Hill, NC, United States., Buckingham W; Reveal Genomics, Barcelona, Spain., Perou CM; University of North Carolina School of Medicine, Chapel Hill, NC, United States., Villagrasa P; SOLTI breast cancer research group, Spain., Guerrero JA; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo (Brazil);, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Mancino M; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo (Brazil);, Spain., Prat A; Hospital Clinic de Barcelona, Barcelona, Spain., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.
Autor:
Han YJ; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Liu S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Hardeman A; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Rajagopal PS; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Mueller J; Department of Pathology, University of Chicago, Chicago, Illinois., Khramtsova G; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Sanni A; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Ajani M; Department of Pathology, College of Medicine, University of Ibadan/University College Hospital, Ibadan, Oyo, Nigeria., Clayton W; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Hurley IW; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Yoshimatsu TF; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Zheng Y; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois., Parker J; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Olopade OI; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2609-2618.
Autor:
Kim H; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Whitman AA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Wisniewska K; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Kakati RT; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Garcia-Recio S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Calhoun BC; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Franco HL; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.; Computational Medicine Program, University of North Carolina, Chapel Hill, North Carolina., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.; Computational Medicine Program, University of North Carolina, Chapel Hill, North Carolina., Spanheimer PM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Surgery, University of North Carolina, Chapel Hill, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 01; Vol. 29 (23), pp. 4894-4907.
Autor:
Tovey H; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Sipos O; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom., Parker JS; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Quist J; The Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Kernaghan S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Kilburn L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium., Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Kennedy RD; ALMAC Diagnostic Services, Northern Ireland, United Kingdom., Roxanis I; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom., Gazinska P; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom.; Biobank Research Group, Lukasiewicz Research Network - PORT Polish Center for Technology Development, Wroclaw, Poland., Pinder SE; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Bliss J; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Perou CM; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Haider S; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom., Grigoriadis A; The Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Tutt A; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom.; The Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Cheang MCU; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 15; Vol. 29 (18), pp. 3691-3705.
Autor:
Xia Y; Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., He X; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Renshaw L; Edinburgh Breast Unit Western General Hospital, Edinburgh, United Kingdom., Martinez-Perez C; Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Kay C; Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Gray M; Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Meehan J; Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Parker JS; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Perou CM; Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Dixon JM; Edinburgh Breast Unit Western General Hospital, Edinburgh, United Kingdom.; Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Turnbull A; Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 15; Vol. 28 (16), pp. 3618-3629.
Autor:
Pascual T; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Tanioka M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Dieci MV; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Pernas S; Institut Catala d' Oncologia (ICO)-Hospitalet, Barcelona, Spain., Gavila J; Fundación Instituto Valenciano de Oncología, Valencia, Spain., Guarneri V; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Cortes J; Oncology department, IOB Institute of Oncology, Barcelona & Madrid, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain., Chic N; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain., Vidal M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Adamo B; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain., Muñoz M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Griguolo G; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Llombart A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Conte P; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Oliveira M; Hospital Arnau de Vilanova, Valencia, Spain.; Hospital Universitari Vall d' Hebron, Barcelona, Spain., Conte B; Department of Medical Oncology, Ospedale Policlinico San Martino, University of Genova, Genova, Italy., Paré L; SOLTI Breast Cancer Research Group, Barcelona, Spain., Galvan P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 01; Vol. 27 (11), pp. 3116-3125. Date of Electronic Publication: 2021 Feb 25.
Autor:
Crosby EJ; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Acharya CR; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Haddad AF; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Rabiola CA; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Lei G; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Wei JP; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Yang XY; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Wang T; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Liu CX; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina., Wagner KU; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan., Muller WJ; Departments of Biochemistry and Medicine, Goodman Cancer Center, McGill University, Montreal, Quebec., Chodosh LA; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania., Broadwater G; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina., Hyslop T; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina., Shepherd JH; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina., Hollern DP; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina., He X; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina., Chai S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina., Ashby BK; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina., Vincent BG; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.; Curriculum in Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, North Carolina.; Computational Medicine Program, University of North Carolina, Chapel Hill, North Carolina., Snyder JC; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina.; Department of Cell Biology, Duke University, Durham, North Carolina., Force J; Department of Medicine, Duke University, Durham, North Carolina., Morse MA; Department of Medicine, Duke University, Durham, North Carolina., Lyerly HK; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina.; Department of Immunology, Duke University, Durham, North Carolina.; Department of Pathology, Duke University, Durham, North Carolina., Hartman ZC; Department of Surgery, Division of Surgical Sciences, Duke University, Durham North Carolina. Zachary.hartman@duke.edu.; Department of Pathology, Duke University, Durham, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Sep 01; Vol. 26 (17), pp. 4670-4681. Date of Electronic Publication: 2020 Jul 30.
Autor:
Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Stover DG; Division of Medical Oncology, Ohio State University College of Medicine, Columbus, Ohio., Guerriero JL; Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts., Dillon D; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Barry WT; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gjini E; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Hartl C; Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts., Lo W; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Savoie J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brock J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Wesolowski R; Division of Medical Oncology, Ohio State University College of Medicine, Columbus, Ohio., Li Z; Department of Pathology, Ohio State University College of Medicine, Columbus, Ohio., Damicis A; Department of Biostatistics, Ohio State University College of Public Health, Columbus, Ohio., Philips AV; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wu Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang F; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sullivan A; NanoString Technologies, Seattle, Washington., Danaher P; NanoString Technologies, Seattle, Washington., Brauer HA; NanoString Technologies, Seattle, Washington., Osmani W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lipschitz M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Hoadley KA; University of North Carolina School of Medicine, Chapel Hill, North Carolina., Goldberg M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Perou CM; University of North Carolina School of Medicine, Chapel Hill, North Carolina., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mittendorf EA; Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. sara_tolaney@dfci.harvard.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Aug 01; Vol. 25 (15), pp. 4644-4655. Date of Electronic Publication: 2019 May 06.
Autor:
Sharma P; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas. psharma2@kumc.edu mmartin@geicam.org., López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., García-Saenz JA; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Khan QJ; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Gómez HL; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Prat A; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Moreno F; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Jerez-Gilarranz Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Barnadas A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Picornell AC; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Monte-Millán MD; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., González-Rivera M; Laboratory of Translational Oncology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Massarrah T; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Pelaez-Lorenzo B; Department of Oncology, Hospital Clínico, Valladolid, Spain., Palomero MI; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., González Del Val R; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Cortés J; Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Fuentes-Rivera H; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Morales DB; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Márquez-Rodas I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Perou CM; Departments of Genetics and Pathology & Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Lehn C; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Wang YY; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Klemp JR; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Mammen JV; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Wagner JL; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Amin AL; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., O'Dea AP; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Heldstab J; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Jensen RA; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Kimler BF; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Godwin AK; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain. psharma2@kumc.edu mmartin@geicam.org.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 01; Vol. 24 (23), pp. 5820-5829. Date of Electronic Publication: 2018 Jul 30.